APOE and dementia: In the Brain DHA Pilot Delivery trial, we found that high-dose TG-based algal DHA supplementation significantly increased CSF DHA levels and that APOE4 was associated with lower brain DHA delivery in persons at risk of dementia but without mild cognitive impairment or dementia (2).